AVEXIS, INC.

Profile

Company Names

AVEXIS, INC.

Addresses

2275 HALF DAY ROAD, SUITE 160, BANNOCKBURN, IL 60015

Phone Numbers

972-725-7797

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$65,000,020.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2015-09-03 
$65,000,020.00 
$65,000,020.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
DEE 
EXECUTIVE OFFICER
AVEXIS, INC.
JOHN 
D. 
HARKEY 
DIRECTOR
EMISPHERE TECHNOLOGIES INC   |  JD HARKEY ENERGY, L.P.   |  AVEXIS, INC.   |  DIALECTIC THERAPEUTICS, INC.
BRIAN 
 
KASPAR 
EXECUTIVE OFFICER, DIRECTOR
AVEXIS, INC.
ANDREW 
F. 
KNUDTEN 
EXECUTIVE OFFICER
AVEXIS, INC.
BONG 
 
KOH 
DIRECTOR
AVEXIS, INC.   |  VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.   |  RAYZEBIO, INC.   |  HYPOTHESIS STUDIO I, L.P.   |  ARTIVA BIOTHERAPEUTICS, INC.   |  KOHFOUNDERS FORMATION FUND, L.P.
JAMES 
 
L-ITALIEN 
EXECUTIVE OFFICER
AVEXIS, INC.
JONATHAN 
 
LEFF 
DIRECTOR
HANA BIOSCIENCES INC   |  RIB X PHARMACEUTICALS INC   |  TALON THERAPEUTICS, INC.   |  N30 PHARMACEUTICALS, INC.   |  AUDENTES THERAPEUTICS, INC.   |  AVEXIS, INC.   |  APRECIA PHARMACEUTICALS CO   |  PROTEON THERAPEUTICS INC   |  DRACEN PHARMACEUTICALS, INC.   |  ARS PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  CHONDRIAL THERAPEUTICS HOLDINGS, LLC   |  LARIMAR THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AEROVATE THERAPEUTICS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  INNERVACE, INC.   |  BIOMX INC.   |  ELION THERAPEUTICS, INC.   |  AXONIS THERAPEUTICS, INC.
PAUL 
 
MANNING 
DIRECTOR
GEN9, INC.   |  ENZYMATICS INC   |  AVEXIS, INC.   |  VERRICA PHARMACEUTICALS INC.   |  ARCHERDX, INC.   |  ADVANTAGENE, INC.   |  TOLERION, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
SUKUMAR 
 
NAGENDRAN 
EXECUTIVE OFFICER
AVEXIS, INC.   |  SOLID BIOSCIENCES INC.   |  TAYSHA GENE THERAPIES, INC.   |  SALIOGEN THERAPEUTICS, INC.   |  AMLOGENYX INC.
SEAN 
 
NOLAN 
EXECUTIVE OFFICER, DIRECTOR
AVEXIS, INC.   |  AFFINIA THERAPEUTICS INC.   |  TAYSHA GENE THERAPIES, INC.
CAROLE 
 
NUECHTERLAIN 
DIRECTOR
AVEXIS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-09-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#